Fiche du document
26 avril 2023
- doi: 10.53738/REVMED.2023.19.824.814
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2023.19.824.814
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/37133942
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_5FF2B1F843099
info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2024-10-26 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Administration Aphrenia Dementias Athymia Aphronesia Alzheimer's dementia Alzheimer diseaseCiter ce document
L. Caranzano et al., « Microangiopathie cérébrale [Cerebral small vessel disease] », Serveur académique Lausannois, ID : 10.53738/REVMED.2023.19.824.814
Métriques
Partage / Export
Résumé
Cerebral microangiopathy is the second leading cause of dementia after Alzheimer's disease and is a co-factor in the majority of dementias. Its clinical manifestations are multiple and include in addition to cognitive and neuropsychiatric manifestations, also problems of gait, urinary continence, and lacunar-ischaemic and haemorrhagic strokes. Patients with similar radiologic images can present very variable clinical pictures, partially resulting from damage to the neurovascular unit, not visible on conventional MRI, and affecting different neural networks. Management and prevention are possible and effective with well-known, readily available and affordable treatments, through aggressive management of cerebrovascular risk factors.